Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 99.2114.8319.94309.00-25.23

What is the latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS is 99.21 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202599.21
Mar202414.83
Mar202319.94
Mar2022309.00
Mar2021-25.23

How is Core EBITDA Growth of SOTAC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 99.21
568.98
Mar2024 14.83
-25.63
Mar2023 19.94
-93.55
Mar2022 309
Positive
Mar2021 -25.23 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹116.6 Cr -6.3% -18.6% -35.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-6.3%

-18.6%

-35.1%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses